The power of immunotherapy plus platinum–based chemotherapy for locally advanced or early stage non-small cell lung cancer | Zendy

Paul Hofman | Zendy

Open Access

The power of immunotherapy plus platinum–based chemotherapy for locally advanced or early stage non-small cell lung cancer

Author(s) -

Paul Hofman

Publication year - 2020

Publication title -

annals of translational medicine

Language(s) - English

Resource type - Journals

eISSN - 2305-5847

pISSN - 2305-5839

DOI - 10.21037/atm.2020.01.91

Subject(s) - medicine , lung cancer , immunotherapy , chemotherapy , stage (stratigraphy) , oncology , platinum , cancer , cancer research , biology , paleontology , biochemistry , catalysis

Université Côte d’Azur, CHU Nice, FHU OncoAge, Laboratory of Clinical and Experimental Pathology, Pasteur Hospital, Nice, France; Université Côte d’Azur, CNRS, INSERM, IRCAN, FHU OncoAge, Team 4, Nice, France; Université Côte d'Azur, CHU Nice, FHU OncoAge, Hospital-Integrated Biobank (BB-0033-00025), Nice, France Correspondence to: Paul Hofman, MD, PhD. Laboratory of Clinical and Experimental Pathology, Pasteur Hospital, 30 avenue de la voie Romaine, BP69, 06001 Nice cedex 01, France. Email: hofman.p@chu-nice.fr. Provenance and Peer Review: This article was commissioned by the Editorial Office, Annals of Translational Medicine. The article did not undergo external peer review. Comment on: Hu H, Zou S, Xu R, et al. Conversion therapy from N3 unresectable lung adenocarcinoma to radical surgery: a case report. Ann Transl Med 2019;7:590.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research